Evidence map›Paper›PMID 35195268›Full record

ArticleTranslational behavioral medicine2022

Reach and effectiveness of the NCI Cancer Moonshot-funded Cancer Center Cessation Initiative.

Heather D'Angelo, Sarah D Hohl, Betsy Rolland, Robert T Adsit, Danielle Pauk, Michael C Fiore, Timothy B Baker

Abstract read
In one paragraph

Article in Translational behavioral medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Smoking in Patients With Cancer: Guidance for Delivering Effective Tobacco Treatment in Cancer Care.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  4. Article
  5. A mixed-methods study exploring free nicotine replacement therapy as a strategy to promote tobacco treatment equity at Cancer Center Cessation Initiative sites.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Development and Demonstration of Tobacco Treatment Measures for Cancer Registries: Novel Metrics for Quality Improvement.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heather D'AngeloCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Sarah D HohlCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Betsy RollandCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Robert T AdsitCenter for Tobacco Research and Intervention, University of Wisconsin-Madison, Madison, WI, USA.
Danielle PaukCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Michael C FioreCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Timothy B BakerCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Funding

NCI NIH HHS #17GZSK0031
6 · The paper itself

Abstract

Smoking cessation results in improved cancer treatment outcomes. However, the factors associated with successful implementation of cessation programs in cancer care settings are not well understood. This paper presents the reach the reach and effectiveness of cessation programs implemented in NCI-Designated Cancer Centers in the Cancer Center Cessation Initiative (C3I). An observational, cross-sectional study was conducted among C3I Cancer Centers from July 1, 2019 and December 31, 2019 (N = 38). Reach was calculated as the proportion of patients reporting current smoking that received cessation treatment and was analyzed overall and by organizational characteristics. Smoking abstinence rates were determined by the proportion of participants self-reporting smoking abstinence in the previous 7 and 30 days at 6 months after treatment. On average, nearly 30% of patients who smoked received any cessation treatment. In-person counseling was most implemented but reached an average of only 13.2% of patients who smoked. Although less frequently implemented, average reach was highest for counseling provided via an interactive voice response system (55.8%) and telephone-based counseling (18.7%). Reach was higher at centers with more established programs, electronic health record referral systems, and higher smoking prevalence. At 6-month follow-up, about a fifth of participants on average had not smoked in the past 7 days (21.7%) or past 30 days (18.6%). Variations in reach by organizational characteristics suggest that leadership engagement and investment in technology-facilitated programs may yield higher levels of reach. Understanding which implementation and intervention strategies facilitate greater cessation treatment reach and effectiveness could lead to improved outcomes among cancer patients who smoke.

Indexed as

NeoplasmsSmoking CessationCounselingCross-Sectional StudiesHealth BehaviorHumansTelephoneCancer centersImplementation outcomesSmoking cessation

Identifiers

PMID35195268
PMCPMC9154282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.